# Benjakul Extract and Loratadine for Treatment Allergic Rhinitis Patients

> **NCT03376594** · PHASE2 · COMPLETED · sponsor: **Thammasat University** · enrollment: 60 (actual)

## Conditions studied

- Allergic Rhinitis

## Interventions

- **DRUG:** Benjakul Extract
- **DRUG:** Loratadine

## Key facts

- **NCT ID:** NCT03376594
- **Lead sponsor:** Thammasat University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-30
- **Primary completion:** 2018-02-01
- **Final completion:** 2018-03-31
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2018-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03376594

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03376594, "Benjakul Extract and Loratadine for Treatment Allergic Rhinitis Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03376594. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*